The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Increased 5-HT 2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [ 11 C]MDL 100,907
Abstract
OBJECTIVE: A previous positron emission tomography (PET) study reported increased serotonin 5-HT(2A) receptor binding in unmedicated depressed patients with high scores on the Dysfunctional Attitudes Scale. The purpose of the present study was to use the highly selective 5-HT(2A) receptor ligand [(11)C]MDL 100,907 in a PET imaging paradigm to assess 1) 5-HT(2A) receptor binding potential in euthymic subjects with a history of recurrent depression and 2) the relationship between receptor binding and scores on the Dysfunctional Attitudes Scale. METHOD: Cortical 5-HT(2A) receptor binding was measured in 20 unmedicated, fully recovered unipolar depressed patients and 20 age- and gender-matched comparison subjects. Regional estimates of binding potential were obtained using a reversible plasma input function compartmental model and the cerebellum as a reference region to estimate the free and non-specifically bound [(11)C]MDL 100,907 in brain tissue. RESULTS: Relative to the comparison subjects, the recovered depressed patients demonstrated significantly higher 5-HT(2A) receptor binding potential in the frontal cortex (mean increase: 19%), parietal cortex (mean increase: 25%), and occipital cortex (mean increase: 19%). 5-HT(2A) receptor binding potential correlated negatively with age in both patients and comparison subjects and positively with the Dysfunctional Attitudes Scale in the recovered patients. CONCLUSIONS: These findings should be considered preliminary but suggest that recovered subjects with a history of recurrent major depression have elevated binding potential of cortical 5-HT(2A) receptors. The correlation of increased 5-HT(2A) receptor binding potential with increased scores on Dysfunctional Attitudes Scale supports earlier work suggesting that increased 5-HT(2A) receptor availability characterizes a group of depressed patients with high levels of dysfunctional attitudes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simplex Method for Function Minimization
Nelder, J. A., & Mead, R. (1965) · The Computer Journal · doi:10.1093/comjnl/7.4.308 · Cited by 28,905
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“Subjects were classified as having recovered from depression on the basis of four criteria: self-reported euthymia following the last episode of major depression, clinician-rated euthymia per clinical interview with an experienced psychiatrist, absence of major depressive episode criteria as judged by the SCID, and a…”
Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005) · Nature Neuroscience · doi:10.1038/nn1399 · Cited by 931
The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain
Burnet, P. W. J., Eastwood, S. L., Lacey, K., & Harrison, P. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00104-x · Cited by 283
Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264 · cited 6×
“As with other imaging studies of 5-HT2A receptor binding in humans, we used the cerebellum as the reference region (14, 30).”
InfluentialMood-induced changes on the implicit association test in recovered depressed patients
Gemar, M. C., Segal, Z. V., Sagrati, S., & Kennedy, S. J. (2001) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.110.2.282 · Cited by 227 · cited 1×
“While Dysfunctional Attitudes Scale scores tend to normalize with clinical improvement, recovered depressed subjects can still demonstrate higher levels of dysfunctional attitudes than never depressed healthy subjects (38, 39).”
Research works printed but not linked: 38
- Duman RS, 2004, Neurobiology of Mental Illness, 421
- 10.1002/(SICI)1096-9861(20000214)417:3<337::AID-CNE7>3.0.CO;2-O · DOI
- 10.1002/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A · DOI · Paper page
- Turecki G, 1999, Am J Psychiatry, 156, 1456, 10.1176/ajp.156.9.1456 · DOI · Paper page
- 10.1001/archpsyc.1990.01810230054009 · DOI · Paper page
- 10.1016/0006-3223(94)90044-2 · DOI
- 10.1001/archpsyc.1989.01810030043006 · DOI
- 10.1016/0006-8993(93)91015-K · DOI · Paper page
- 10.1001/archpsyc.1993.01820220066007 · DOI · Paper page
- 10.1016/S0893-133X(01)00393-1 · DOI · Paper page
- 10.1016/S0022-3956(03)00050-5 · DOI · Paper page
- 10.1016/S0969-8051(99)00022-0 · DOI
- 10.1016/S0969-8051(00)00212-2 · DOI
- 10.1016/0024-3205(96)00013-6 · DOI
- 10.1097/00004647-200006000-00002 · DOI
- Ito H, 1998, J Nucl Med, 39, 208
- 10.1002/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X · DOI
- Mawlawi O, 2001, J Nucl Med, 42, 106P
- Hinz R, 2006, Cunningham VJ
- 10.1001/archpsyc.61.12.1271 · DOI · Paper page
- 10.1006/jrpe.1994.1019 · DOI · Paper page
- 10.1088/0031-9155/45/9/313 · DOI
- Ranicar AS, 1991, Med Prog Technol, 17, 259
- 10.1038/sj.mp.4001401 · DOI · Paper page
- 10.1016/0895-6111(89)90285-1 · DOI · Paper page
- 10.1002/ana.410150302 · DOI · Paper page
- 10.1016/j.biopsych.2003.08.015 · DOI · Paper page
- Laruelle M, 1994, J Nucl Med, 35, 743
- 10.1097/00004647-199704000-00009 · DOI · Paper page
- Meyer JH, 1999, Am J Psychiatry, 156, 1029, 10.1176/ajp.156.7.1029 · DOI · Paper page
- Cohen J, 1988, Statistical Power Analysis for the Behavioural Sciences
- 10.1002/syn.10268 · DOI
- Talbot PS, 2004, Biol Psychiatry, 55, 63S
- 10.1017/S0033291701003932 · DOI
- 10.1037/0021-843X.108.1.76 · doi:10.1037/0021-843x.108.1.76
- 10.1192/bjp.180.1.24 · DOI
- 10.1124/mol.63.5.961 · doi:10.1124/mol.63.5.961
- 10.1093/cercor/13.8.870 · DOI · Paper page
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Neurobiology of chronic mild stress: parallels to major depression
Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382
Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565653 · Cited by 381
Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13249 · Cited by 347
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
Kometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.005 · Cited by 298
Meyer, J. H. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0709 · Cited by 272
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Frokjaer, V. G., Mortensen, E. L., Nielsen, F. Å., Haugbol, S., Pinborg, L. H., Adams, K. H., Svarer, C., Hasselbalch, S. G., Holm, S., Paulson, O. B., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.009 · Cited by 242
Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder
Fonseka, T. M., MacQueen, G. M., & Kennedy, S. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.049 · Cited by 185
Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., Clark, M., Sacher, J., Voineskos, A. N., & Houle, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.156 · Cited by 182
Fisher, P. M., Meltzer, C. C., Price, J. C., Coleman, R. L., Ziolko, S. K., Becker, C., Moses-Kolko, E. L., Berga, S. L., & Hariri, A. R. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp022 · Cited by 125
Bhagwagar, Z., & Cowen, P. J. (2008) · Psychological Medicine · doi:10.1017/s0033291707001250 · Cited by 124
Self-citationPersistent β 2 *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Saricicek, A., Esterlis, I., Maloney, K. H., Mineur, Y. S., Ruf, B. M., Muralidharan, A., Chen, J. I., Cosgrove, K. P., Kerestes, R., Ghose, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101546 · Cited by 118
Self-citationPharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Lyons, T., & Carhart-Harris, R. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01721 · Cited by 77
Frokjaer, V. G., Vinberg, M., Erritzoe, D., Baaré, W., Holst, K. K., Mortensen, E. L., Arfan, H., Madsen, J., Jernigan, T. L., Kessing, L. V., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.218 · Cited by 53
Hayley, S., Scharf, J., & Anisman, H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.023 · Cited by 48
Simpson, H. B., Slifstein, M., Bender, J., Xu, X., Hackett, E., Maher, M. J., & Abi-Dargham, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.023 · Cited by 47
Stenbæk, D. S., Kristiansen, S., Burmester, D., Madsen, M. K., Frokjaer, V. G., Knudsen, G. M., & Fisher, P. M. (2019) · Human Brain Mapping · doi:10.1002/hbm.24511 · Cited by 11
Johansen, A., Holm, S., Dall, B., Keller, S., Kristensen, J. L., Knudsen, G. M., & Hansen, H. D. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0527-4 · Cited by 10
“5-HT2ARs are widely distributed in the cerebral cortex [2] and has been linked to neuropsychiatric disorders such as depression [3, 4].”
Background
Metadata
- Authors
- Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., & Grasby, P.
- Venue
- American Journal of Psychiatry
- Published
- 2006-09
- Volume
- 163
- Issue
- 9
- Pages
- 1580-1587
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1990644324
- Cited by
- 214
- References
- 6
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.